In Bloomberg Law, Health Care Attorneys Evaluate New Legal and Business Risks in Health Care Transactions Related to COVID-19
As the U.S. economy reopens and health care transactions resume, parties to mergers, acquisitions, joint ventures, and affiliations will need to evaluate new legal and business risks related to the coronavirus pandemic.
In a Bloomberg Law article, health care partner and co-chair Tim McCrystal and health care associates Christina Bergeron and Elizabeth King (all of Boston) discuss key topics that organizations should consider when evaluating health-care transactions during and after the COVID-19 crisis.
The authors note that the pandemic has created new legal and business risks associated with health care transactions. These issues are important because they may impact a target’s current and future financial performance even after the pandemic ends.